Milk is the only biomaterial that evolved under the Darwinian selective pressure to nourish growing mammals. The purpose of this article is to review the scientific research that is using new techniques of integrating biological sequence, structure and function, to understand the innovative biology underlying the products of that evolutionary pressure. As it emerges that milk is actively communicating between the maternal mammary epithelia and the infant's gastrointestinal system, actively directing and educating the immune, metabolic and microflora systems within the infant, enhancing nutrient absorption and delivery, and conferring multiple means of protection, nutritionists are gaining a host of new molecular targets towards which to build scientific strategies for future foods and clinical applications. As new components and functions are being discovered in milk by using traditional methods and modern genomic tools, the complexities of demonstrating in vivo, and particularly in humans, the functional mechanisms behind milk's newly observed physiological benefits are becoming the next challenge of this rapidly growing field.
Introduction
Milk is an unusual biological¯uid, having evolved as the lactation-speci®c secretions of a distinct class of epithelial cells contained within the mammary gland of mammalian females. Traditionally, milk has been viewed as a package of essential nutrients (vitamins, minerals, essential amino acids and fatty acids) delivered as a protein, lactose and fat-rich colloidal¯uid. Milk is becoming recognized, however, as a remarkably diverse cocktail of unusually bioactive components including complex proteins, lipids, carbohydrates and polynucleotides. Recent studies have shown that the presence and abundance of these components offer a wide variety of physiological, protective and nutritional functions beyond the provision of essential nutrients and fuels. This understanding of molecules with actions beyond the simple provision of essential nutrients is explained by the origin of milk. Milk has evolved to be a mammalian infant's only food. It is dif®cult to imagine an agent more directly causal to the genetic success of offspring than mammalian milks. The Darwinian selection pressure on these¯uid secretions of mammary epithelia as a supportive source of nutrition and biologically active substances was intensive. The genetic legacy of this strong selective pressure during evolution as de®ned by the components of milk is encoded by the genes that are responsible for producing them (i.e. the`milk genome'). Traditional investigative approaches are merging with the tools of modern genomics to discover the details of this genetic legacy and to build on this knowledge to put predictive bene®ts into all foods. As the nutrition community rede®nes its future within the functional genomics era, milk can provide a blueprint as to how food molecules interact with speci®c host targets to improve individual health and quality of life. While many tools are at hand, however, some key elements necessary to bringing milk's bene®ts to scienti®c reality are still missing. Foremost of these are the means to demonstrate the mechanisms together with the ef®cacy by which milk components provide health bene®ts in vivo.
Milk composition
As a result of the enabling power of the new technologies of genomics, molecular biology and analytical chemistry, an ongoing stream of reports on milk constituents have appeared during the years 2000, 2001 and 2002, and have been reviewed from various perspectives [1,2 . ,3±13]. The challenge when discovering new constituents in milk is to understand the basis of the functional value that these constituents provide to the health of either the offspring or the mother. While it can certainly be argued that nature didn't put things in milk for no reason and the search for function in milk is likely to be a highly successful pursuit, the details of the mechanisms behind these bene®ts will be dif®cult to deduce. Most traditional strategies to identify new components in milk have used in-vitro bioassays to test for suspected physiological or biochemical effects of isolated milk fractions. Itoh et al. [14] described the presence and relative abundance of hepatocyte growth factor in human breast milk as a function of lactation in full term and preterm pregnancies. The inordinate abundance of the human growth factor in colostrum and in preterm milks led these investigators to the hypothesis that human growth factor is a trophic factor for intestinal cells by virtue of its ability to stimulate hepatocyte differentiation in vitro. Karhumaa et al. [15 . ], in an interesting discovery, identi®ed carbonic anhydrase VI to be constitutively expressed in human and rat milk. The previously described presence of this component in saliva and its ability to stimulate oral epithelia differentiation and maturation led the authors to the speculation that its presence in milk would have a similar stimulating activity for the newborn intestinal development. Sternhagen and Allen [16] described an unexpected ability of a-lactalbumen to regulate the growth of cancerous cells in vitro. It is not clear whether this activity would persist in vivo or what the mechanism of its action is; nevertheless, the results imply that even well described milk components may yet be found to possess unexpected actions. Magi et al. [17 . ] described a macrophage migration inhibitory factor in human milk, and further mapped its location to the aqueous phase between milk fat globule and the membrane. The speci®c site of this component led the authors to the intriguing speculation that by localizing labile factors to this compartment, the complex structure of milk could alter the delivery of molecules to different sections of the gut.
Most of the research on the bene®ts of milk to health has focused on the proteins as the direct products of speci®c genes. Yet the secondary products of metabolism within the mammary gland are quickly being recognized for their unusual contributions to nutrition. Examples are the oligosaccharides and glycoconjugates and Gopal et al.
[7] reviewed their suspected biological functions in human milk. These components are judged at present to provide protection against pathogens by acting as competitive inhibitors for the binding sites on the epithelial surfaces of the intestine. The authors state that these bioactive molecules are likely to be bene®cial for human nutrition throughout life. The lipid fraction from cow's milk consists of many bioactive substances. The consequences to metabolism of these substances have been studied over the years and found to be both positive and negative depending on the individual's overall health and metabolic status. The most abundant lipid components are the richly varied fatty acids. Molkentin [9] reviewed the antiatherogenic and anticarcinogenic activities of conjugated linoleic acids and the proatherosclerosis and coronary heart disease properties of trans fatty acids. Unfortunately and discouragingly, to date no thorough studies have established the molecular basis of the effects of different trans fatty acids. Thus it is impossible to reach any conclusions as to whether the speci®c trans fats of milk are indeed deleterious to risk of heart disease.
Milk is notable for the quantity of complex lipids, particularly phospholipids and sphingolipids. This abundance is the result of the interesting biosynthetic process of milk fat globule secretion in which the globules are enrobed in an entire layer of epithelial cell plasma membrane. The striking complexity of lipids that result from this process and the unique colloidal structure of fat globules are still being studied, but already the complex lipids of milk are proving to provide distinct physiologic effects. Schmelz et al. [18] , extending their previous work on sphingomyelin, studied a variety of sphingolipids in carcinogen-treated (dimethylhydrazine) mice. All sphingolipids that were assessed produced a signi®cant reduction in the early stages of tumor development, implying that the key determinant of ef®cacy was the common hydrolysis product of sphingolipids, ceramides.
Although not as familiar constituents of milk as proteins and lipids, nucleosides and nucleotides are natural bioactive substances in milk and colostrum. A thorough review of the nonprotein nitrogen milk components was presented by Schlimme et al. [8] . These authors discuss the biological role of nucleotides, nucleosides and nucleobases and their roles in regulation of diverse body functions. Dietary nucleotides affect immune modulation by enhancing antibody responses of infants. The dietary nucleos(t)ides contribute to iron absorption in the gut and in¯uence desaturation and elongation rates of fatty acid synthesis. The tantalizing possibility that polynucleotides could provide speci®c actions when consumed in milk has not yet been explored.
Functions of milk components
The era of functional genomics is pushing the limits of biological science both broader and deeper. The breadth of knowledge of biological organisms from ancient bacteria to humans, especially at the genetic level, is increasing exponentially. Genomics tools are beginning to be applied to milk-related questions. Scientists are pro®ting from the fundamental redundancy of the evolution of biological sequence/structure/function within genes across species. Thus the discovery of a gene's function in virtually any organism can lead rapidly to its identi®cation and functional assignment in much of the rest of biology. A vivid example of cross-species comparisons providing immediate identi®cation of genes and functions is that of diacylglycerol acylCoA transferase (DGAT) genes. DGAT1 was identi®ed as the gene encoding for the ®nal step in the biosynthesis of triglycerides [19] . Remarkably, in mice in which the DGAT1 gene was knocked out, blood and tissue levels of triglyceride were near normal, clearly implying the presence of another DGAT activity. Genomics searches failed to ®nd a gene with structural or sequential similarity to DGAT1 as a candidate DGAT2. A gene from the fungus Mortierella rammaniana, however, was recently identi®ed as a fungal DGAT [20] , and when the Farese group conducted a sequence search using the M. rammaniana sequence in mammalian libraries, multiple homologous genes appeared, including the putative DGAT2 [21 . ]. Investigations of milk and milk production are already discovering the implications of these genetic breakthroughs. Polymorphisms in the structural gene of bovine DGAT1 were recently shown to be associated with variations in milk fat content of bovine milk, explaining a previously recognized quality trait locus for milk fat on chromosome 14 [22 . ]. Now because of molecular understanding assembled from biological research, dairy researchers have in hand a molecular target for screening and modifying milk fat production.
The depth of knowledge of milk components is being driven by similar developments in the techniques of analytical chemistry. Rapid isolation, sequencing, structure elucidation and comparison of the functionality of genetic elements are the bases of the modern ®eld of investigative biotechnology. Improvements in more traditional analytical platforms including mass spectrometry, nuclear magnetic resonance and many others, however, are still necessary to address the complexity of milk components. Peterson et al. [23] reviewed the knowledge gained of the structure and function of the relatively uncharacterized milk fat globule membrane glycoproteins. These complex products of translation and post-translational modi®cations still push several modern analytical techniques to the limits of their capabilities.
As a result of the advances in the breadth and depth of biological research tools, more is being learned about the minor components of milk. Nevertheless, the functions of the components of milk as food/nourishing molecules are not simply inferred from comparing the biochemical functions of homologous gene products in other cells/ tissues/species. The practice of determining why each of these components was selected by evolutionary pressure to be included in mammalian milks remains a complex and creative deductive process. Transforming growth factor-b is such an example. Discovered in signi®cant quantities in milk, this protein was initially recognized as a cofactor in epithelial cell differentiation and immune regulation. The possibility that the presence of this compound in milk stimulates appropriate maturation of naive infant intestine was advanced in a thorough review by Donnet-Hughes et al. [13] . The review discussed mechanisms, targets and even went further to illustrate the importance of milk processing in maintaining the integrity and activity of transforming growth factor-b.
The principle of molecular pleitropism, one component possessing multiple actions, has become a theme of milk. The remarkable properties of lactoferrin, which include modifying iron chemistry, bioavailability and toxicity as an intact protein, then releasing peptides on hydrolysis ± some of which are antipathogenic while others are probi®dogenic ± are just part of the myriad of actions of this single gene product. Lactoferrin is indeed thè poster-child' of value-added food ingredients [2 . ]. This principle of pleitropism was seen in several additional studies, showing that peptides produced by hydrolysis of milk proteins exhibit quite distinctive properties from the native proteins. The hypotensive properties of milk casein peptides have been identi®ed, at least in part, as a group of tripeptides with the ability to inhibit angiotensin converting enzyme. In studies to determine if this in-vitro inhibitory activity is relevant when these peptides are consumed, one of these, val pro pro, was demonstrated to be transported by intestinal cells in culture (Caco-2 cells) [24] . Other research has focused on milk peptides as inhibitors of platelet clotting and thrombosis, as reviewed by Rutherfurd and Gill [6]. The peptides most reported to inhibit platelet aggregation include a number derived from the glycomacropeptide segment of k-casein and KRDS, a peptide from lactoferrin. These peptides have similar structures but different modes of action. Again, whether these peptides are involved in the antithrombotic properties of milk has yet to be ascertained. Another of the many bioactive peptide sequences of a milk protein are the phosphopeptides released by tryptic hydrolysis of casein. Scholz-Ahrens and Schrezenmeir [4] reviewed studies on phosphopeptides dating back 50 years. Most of the studies were related to calcium metabolism. From various study results, it was concluded that phosphopeptides had positive effects on mineral solubility and absorbability, and bone mineralization under speci®c experimental conditions. The overall results indicate that phosphopeptides could have a bene®cial effect on bone health for some groups of the population, but de®nitive studies in vivo have not been carried out. Another recent review [11] emphasizes immune and nonimmune protective functions of both major and minor nutrients in human milk. Additional emphasis was placed on enzymes in milk with bene®cial digestive functions in the newborn.
Research aiming to discover the functions of milk components is still hampered by the dif®culty in establishing the molecular targets of their action. Without speci®c targets, how can milk components be rigorously tested to be active or not? It is especially dif®cult to establish whether a lack of effect is truly an indication that milk is not active or that the surrogate endpoint is inadequate in accurately assessing a physiological/biochemical change, that is, a type 2 error. Witness the study by Matar et al. [25 . ] who investigated the effect of probiotics and fermented milk on indices of immune function and cancer cell elimination. The authors addressed a key question for fermented milks and yogurts: is the hydrolysis of milk components by probiotic bacteria a vital aspect of the overall bene®ts of fermented milks? The authors assembled a precise approach to address the complexity of yogurt by fermenting milk with Lactobacillus helveticus wild type or its nonproteolytic variant with or without speci®c protease activity. Feeding these products to mice for 3 days led to statistically signi®cant numbers of secretory IgA (sIgA) cells in the mice, con®rming an effect on immunity. Discouragingly, the lack of clear targets against which the speci®c actions of putative peptides could be examined limited the study's impact, even though signi®cant effects were observed. Similarly, a positive, moderate effect of a beverage containing milkbased micronutrients with added vitamins and minerals was demonstrated in a clinical trial of osteoarthritis [26] . Again, however, the lack of mechanistic information will delay approaches to optimizing these bene®ts.
Functions of intact milk
Milk will always be recognized as a synergistic mixture of multiple interacting factors. Hence many of the functions/actions/bene®ts of milk are best, and perhaps only, evaluated effectively when milk is studied in a relatively complete form. Several studies reported in the past year have documented new effects of milk consumption using innovative approaches to understanding intact milk as a nourishing food. One approach has been to demonstrate how the properties of milk vary during lactation. Colostrum was shown previously to stimulate muscle growth in newborn piglets. Fiorotto et al. [27] have extended this work to demonstrate colostrum-containing factors that stimulate myo®brillar ribosomal accretion and speci®c messenger RNA abundances in newborn piglets. In a related approach, Rauprich et al. [28] compared newborn calves fed colostrum or formula. In addition to a substantial improvement in absorptive capacity determined using the serum marker xylose in the colostrum-fed animals, the study found various differences in blood lipids, proteins, glucose and hormones consistent with altered metabolism throughout the feeding periods. A similar study [29] sought to explore the role of the bioactives in colostrum by comparing colostrum and milk replacer in neonatal calves at high and low nutrient densities. Again, absorptive capacity was improved by colostrum. Furthermore, only the colostrum-fed calves were able to convert the higher density feeds into metabolic advantage, suggesting that the colostrom provided bene®ts beyond greater absorption.
Compositional differences between milk of different lactation stages were examined by l'Abbe and Friel [30] . The composition differed between preterm and full term human milks, and the authors highlighted the differences in the content of the antioxidant enzymes glutathione peroxidase (higher in preterm milk) compared with superoxide dismutase (higher in full term milk). As a conclusion, the authors suggested that preterm infants may be at a disadvantage due both to the quantity and composition of preterm milk.
The potential of milk to interact with adult health remains an area of active research and a signi®cant breakthrough was achieved in, surprisingly, obesity prevention. The sensitivity of the adipocyte to various nutrients and hormones has been demonstrated over several years, and it was perhaps naively thought that there were few surprises left in the regulation of signaling cascades in adipocytes by essential nutrients. Zemel [31 . . ] revealed that the calcitrophic hormone 1,25-dihydroxy vitamin D 3 binds to adipocytes and promotes calcium in¯ux causing a constitutive inhibition of lipolysis. This mechanism effectively uncouples lipolytic hormones from hormone-sensitive lipase, implicating low dietary calcium as a potential cause of energy dysregulation and obesity. With such knowledge, milk and its abundant and available calcium is emerging as one of the solutions to obesity, and yet milk has been implicated for the past two decades as one of the problems. Even more recently, an epidemiologic study examined the gender, race and environmental correlates to the various metabolic problems of type 2 diabetes, primarily insulin resistance [32 . . ]. In addition to ®nding a signi®cant negative correlation with obesity, the strongest dietary protection from insulin resistance in a population of adult Americans was dairy consumption. The authors emphasized that the odds ratio in the population for insulin resistance, when consuming the recommended dairy intake per week (i.e., three or more servings per day), was 0.27 relative to the odds ratio of 1.0 with zero dairy intake.
Aspects of milk and its effect on the risk of cardiovascular disease continue to be addressed. Although milk has the reputation of being a potential promotor of atherosclerosis and coronary heart disease, based on its content of cholesterol and saturated fatty acids, Pfeuffer and Schrezenmeir [3] reviewed evidence that milk may not affect risk adversely in all individuals. Milk components such as calcium and bioactive peptides may protect against hypertension. Folic acid, vitamin B6 and vitamin B12 may contribute to low homocysteine levels. As also reviewed by Molkentin [9], conjugated linoleic acid may be hypolipidaemic, and have antiatherosclerotic properties. The author points out that from epidemiological data, milk and milk products together with cereals and vegetables are healthy components of the diet. High blood pressure is a signi®cant public health problem worldwide. Groziak and Miller [5] reviewed studies that have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension. Several components of milk affect blood pressure, including minerals and peptides released during digestion of milk proteins.
Milk and nourishment of its second consumer: intestinal microflora
One of the most fascinating properties of milk is its ability to selectively nourish bene®cial bacterial populations in the infant intestine at the expense of deleterious bacteria and pathogens. The ability of milk to provide this bene®t to all ages remains one of the breakthrough research areas in milk-related science. Liepke et al. [33 . ] developed an interesting separation/identi®cation system for antimicrobial peptides generated in milk by peptic hydrolysis using a bioguided chromatographic strategy. Using this approach they discovered a previously unknown caseinopeptide that they described as possessing broad antimicrobial activity. The selectivity of milk's effects are illustrated by the recent report of a peptide from human lactoferrin that actively stimulates the growth of the bene®cial bi®dobacteria [33 . ]. Duffy [34] provided a very thought-provoking review of the role of probiotic bacteria in guiding intestinal maturation. In particular, how does the endogenous micro¯ora participate in the processes leading to or preventing bacterial translocation across the infant intestine? The potential biotherapeutic use of the bene®cial anaerobic bacteria Lactobacillus and Bi®dobacterium to combat bacterial translocation, particularly in the developing gut of premature newborns, was also described. Adherent human bi®dobacterial strains exhibit inhibitory effects against colonization by a number of diarrheagenic bacteria, including Escherichia coli 0157 and Salmonella typhimurium, and murine and rhesus rotaviruses in various in-vitro and in-vivo models. Oddy [35] reviewed the evidence that milk reduces the incidence of pathogenic episodes in breast-fed infants, concluding that breastfeeding should be recommended for the ®rst 6 months of life.
Finally, in a demonstration of the potential of genetic engineering to affect the health of production animals, Kerr et al. [36 . ] describe the transgenic expression of a bacteriocin lysostaphin by mammary epithelia in mice that protected the animals against a major mastitis pathogen, Staphylococcus aureus.
Conclusion
The growth of enabling technologies in biological research is poised to catalyze studies on understanding how milk provides nutritional and physiological bene®ts to growing mammals. This knowledge is already being applied to improve foods for humans and animals of all ages. In particular, the emergence of genomics provides new gene-based approaches to identify the molecules that are present in milk or are responsible for producing the molecules in milk. Scientists are still faced with the complex and dif®cult challenge of annotating these genes and assigning their bene®ts to speci®c molecular targets and functions. Several studies point to a glaring need for models that will rigorously test proposed functions of milk and milk components. Only by clear demonstration of cause and effect can it be concluded that molecules provide speci®c bene®ts such that those bene®ts are then delivered via speci®c food products to appropriate consumers. The challenge is not simple and requires new perspectives for investigation. Many of the bene®ts inferred for milk-derived molecules are likely to appear to be sporadic. That is, a molecule/ingredient that provides protection from a stress can only be appreciated when the consumer is faced with that speci®c stress, metabolic challenge or hostile threat. Models that bring these speci®c challenges as quantitative input variables will be necessary in ®nally establishing how speci®c molecules, and indeed complex interactions between molecules in milk, function. Transgenic animal models, both knockouts and`knock-ins' that have been so successful in recent research on biologically active pharmaceuticals, represent an obvious approach to resolve this need. Even when these animal models are successful, bringing our understanding of milk's bene®ts from molecular prediction to true human demonstration will require highly creative scienti®c strategies and approaches. Fortunately, the bene®ts to human health will justify the investment.
